FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.
Bandurska-Luque A, Löck S, Haase R, Richter C, Zöphel K, Abolmaali N, Seidlitz A, Appold S, Krause M, Steinbach J, Kotzerke J, Zips D, Baumann M, Troost EGC.
Bandurska-Luque A, et al. Among authors: abolmaali n.
Radiother Oncol. 2019 Jan;130:97-103. doi: 10.1016/j.radonc.2018.09.008. Epub 2018 Oct 4.
Radiother Oncol. 2019.
PMID: 30293643